GSI Group expands Platform with Acquisition of GenesisBPS
GenesisBPS strengthens GSI Group's global platform with mission-critical blood processing equipment and consumables
GSI Group provides a wide range of essential laboratory single use products, precision benchtop instruments, and related accessories. The platform has built a global reach, with locations across the
Founded in 1990, GenesisBPS has become a premier provider of mission-critical blood processing and collection instruments, consumables, and accessories. Its products are widely used in blood banks, hospitals, clinical laboratories, and cellular therapy applications where they play an essential role in ensuring the safe collection, processing, and storage of blood and other biological fluids.
"We are excited to have GenesisBPS join GSI as part of the expanding global platform," said
"GenesisBPS is an outstanding strategic fit for GSI," said
The addition of GenesisBPS further strengthens GSI Group's position as a leading provider of laboratory benchtop equipment and single use product. The GSI Group platform will continue strategic acquisitions of leading brands of benchtop equipment and consumables across
About GSI Group Holdings
GSI Group Holdings is a US-based holding company of leading branded laboratory consumables and benchtop equipment for the scientific, academic, and industrial communities. GSI Group has an unmatched geographic footprint with locations on both the east and west coasts of the US as well as offices in
View original content to download multimedia:https://www.prnewswire.com/news-releases/gsi-group-expands-platform-with-acquisition-of-genesisbps-302572648.html
SOURCE GSI Group Holdings
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southern Company announces offerings of $650 million in aggregate principal amount of Convertible Senior Notes due December 15, 2027 and $1.5 billion in aggregate principal amount of Convertible Senio
- Varda Announces Biopharma Leader Mikael Dolsten will Join Board as Space-Based Pharmaceutical Manufacturing Accelerates
- NESR to Release Second Quarter 2026 Financial Results on August 10th
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share